Answers are grounded in this paper and cite their sources.
Patient stratification by MMR status may provide a more tailored approach to colon cancer adjuvant therapy. These data support MMR status assessment for patients being considered for FU therapy alone and consideration of MMR status in treatment decision making.
No takes yet. Share an insight, caveat, or question.
Sargent et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: